Study design
fasting blood glucose, postprandial blood glucose, allergy, high-density lipoproteincholesterol, hypertension
ALLERGY, HYPERTENSION
Eligible MMD patients with hypertension were invited to participate in the study. Written informed consent was obtained from each participant before the study. The study was registered at the Chinese Clinical Trial Registry (registration number: ChiCTR2200065111, date of registration: 28/10/2022).The clinical pharmacists providing MTM services reviewed the assessment method of blood pressure used at the clinic with the medical director to ensure consistency of the measurements between the intervention group and the control group before study initiation. All inpatients collected blood pressure data using the yuyue brand (U30 type) arm electronic sphygmomanometer. Before taking antihypertensive drugs on the morning of the measurement day, the patient was placed in a sitting or lying position in a calm state and measured by the clinical pharmacists. The mean value of three consecutive blood pressure measurements was taken.Following the five core elements of the MTM service model, the clinical pharmacists in Taizhou People’s Hospital conducted the MTR at the initial phase of admission, integrated all the drugs used by patients, and collated and completed patients’ drug records (including medication during hospitalization). Meanwhile, a face-to-face questionnaire was conducted to collect patients’ demographics (age, education level, pre-retirement occupation, living structure, family monthly income), NCDs status (types of NCDs, past allergy history, medical history, and current medication), health-related influencing factors (smoking, drinking, BMI, and family medical history, comorbidities), patients’ clinical indicators (required parameter: blood pressure; optional parameters according to comorbidities: heart rate, alanine aminotransferase, aspartate aminotransferase, urea nitrogen, serum creatinine, estimated glomerular filtration rate, fasting blood glucose, 2-h postprandial blood glucose, glycosylated hemoglobin, total cholesterol, triglyceride, low-density lipoprotein cholesterol, high-density lipoproteincholesterol, uric acid, etc.), average daily medication therapy cost, EQ-5D utility value, and DRPs status. After completing the questionnaire, the pharmacists checked each patient’s medication history in the information system of Taizhou People’s Hospital (HIS).Clinical pharmacists from Taizhou People’s Hospital followed up with the patients via telephone and face-to-face interviews in the first, third, sixth, and twelfth months after discharge. The follow-up was on DRPs inquiry and medication education. The control group received general pharmaceutical care. The follow-up content for the control group included clinical indicators, names, and dosages of drugs used, EQ-5D utility value, hospitalization, and DRPs status. The follow-up content of the intervention group was based on the follow-up contents of the control group; the medication reconciliation was carried out for the patients with multi-drug usage, as shown in Fig. Service flow chart of the intervention group